2024
13/Dec
Tad Carter
My Blog
2025
8/Jan
The advantages of mRNA vaccines for cancer therapy I find what BioNTech is doing something is truly exciting. What makes this super cool? It’s not just the science—it’s the ambition. Combining AI, innovative trials, and partnerships, BioNTech is proving that curing cancer isn’t a far-off vision—it’s happening now. Their work on BNT327—a bispecific antibody targeting […]
Keep Reading
2023
24/May
Matthew Dickinson | [email protected] What can you do to help your product reach the clinicians, doctors, physicians and patients who need it most? Take a closer look into the considerations and strategy around successful pharma marketing. MARKETING IN THE PHARMACEUTICAL INDUSTRY Alongside healthcare services and medical equipment supply, pharmaceuticals is one of the three big […]
Keep Reading
2023
18/Feb
Terumo Aortic announces US FDA approval for Relay®Pro Endovascular Device
Keep Reading
2021
24/Jun
https://www.biopharma-reporter.com/Article/2020/09/23/Viral-vector-production-demand-will-ultimately-exceed-the-current-global-capacity?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright
Keep Reading
2021
28/Apr
2020
14/Aug
BREAKING NEWS: U.S. FDA Oncologic Drugs Advisory Committee voted nine to one in favor of Mesoblast’s remestemcel-L (Ryoncil™) for efficacy in children with steroid-refractory acute graft versus host disease (SR-aGVHD). This is an important milestone for allogenic cell therapies being developed to treat critical inflammatory diseases, including #COVID19. RYONCIL has been accepted for Priority Review by […]
Keep Reading
In a world driven by automation and rapid change, those who think broadly, adapt quickly, and connect the dots others fail to see will thrive. Whether in healthcare, business, technology, or creative pursuits, generalists are uniquely positioned to lead.
Keep Reading